Fate Therapeutics, Inc. Competitors
| Symbol | Company | Share Price | Market Cap | P/E Ratio | Employee Count | Revenue |
|---|---|---|---|---|---|---|
 ATRA
|
Atara Biotherapeutics, Inc. | $11.35 | $63.68 M | -0.25 | 165 | $8.57 M |
 BEAM
|
Beam Therapeutics Inc. | $24.11 | $1.91 B | -14.51 | 472 | $377.71 M |
 BPMC
|
Blueprint Medicines Corporation | $90.23 | $6.47 B | -21.48 | 638 | $249.38 M |
 CRBU
|
Caribou Biosciences, Inc. | $1.99 | $176.12 M | -1.41 | 158 | $34.48 M |
 CRSP
|
CRISPR Therapeutics AG | $47.29 | $4.91 B | -21.43 | 407 | $371.21 M |
 EDIT
|
Editas Medicine, Inc. | $2.52 | $435.86 M | -2.56 | 265 | $78.12 M |
 IPSC
|
Century Therapeutics, Inc. | $1.25 | $244.54 M | -1.32 | 152 | $2.24 M |
 LIFE
|
aTyr Pharma, Inc. | $1.90 | $131.12 M | -2.16 | 56 | $353,000 |
 NTLA
|
Intellia Therapeutics, Inc. | $14.17 | $2.19 B | -4.23 | 526 | $36.28 M |
 PRME
|
Prime Medicine, Inc. | $3.19 | $788.60 M | -3.01 | 234 | $0 |
 RCUS
|
Arcus Biosciences, Inc. | $14.43 | $1.41 B | -4.98 | 577 | $117.00 M |
 RLAY
|
Relay Therapeutics, Inc. | $4.88 | $1.05 B | -3 | 294 | $25.55 M |
 SANA
|
Sana Biotechnology, Inc. | $2.35 | $1.55 B | -4.59 | 328 | $0 |
 THRX
|
Theseus Pharmaceuticals, Inc. | $4.07 | $181.50 M | -3.03 | 38 | $0 |
 VERV
|
Verve Therapeutics, Inc. | $4.49 | $409.24 M | -1.82 | 255 | $11.76 M |